Are You Looking for a Top Momentum Pick? Why Commercial Metals (CMC) is a Great Choice
Does Commercial Metals (CMC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Earnings Estimates Moving Higher for Commercial Metals (CMC): Time to Buy?
Commercial Metals (CMC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Are Basic Materials Stocks Lagging Commercial Metals (CMC) This Year?
Here is how Commercial Metals (CMC) and Fresnillo PLC (FNLPF) have performed compared to their sector so far this year.
3 Stocks With Upgraded Broker Ratings for Robust Returns
Broker upgrades fuel optimism for Newmont, Commercial Metals and Cenovus Energy as earnings outlook strengthens.
Commercial Metals Q4 Earnings Beat Estimates, Sales Rise Y/Y
CMC's Q4 earnings and sales beat estimates, with strong segment gains and a new $1.84B acquisition boosting growth prospects.
Commercial Metals (CMC) Surpasses Q4 Earnings and Revenue Estimates
Commercial Metals (CMC) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $0.9 per share a year ago.
Unlocking Q4 Potential of Commercial Metals (CMC): Exploring Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Commercial Metals (CMC) for the quarter ended August 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Commercial Metals (CMC) Reports Next Week: Wall Street Expects Earnings Growth
Commercial Metals (CMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unicycive Therapeutics: Manageable CMC Speed-Bump--Pill-Burden Edge Intact, Buying
Initiating coverage on Unicycive Therapeutics, Inc. with a Buy rating and $6 price target, as the recent FDA CRL is manufacturing-related and resolvable. OLC's ultra-low pill burden and strong patient preference position it for significant market share in the $2.7B phosphate binder market for dialysis patients. DCF valuation supports attractive upside even with conservative 20% peak market share, with backup manufacturing in place and 80% historical CRL resolution rate.
Commercial Metals (CMC) Up 7.3% Since Last Earnings Report: Can It Continue?
Commercial Metals (CMC) reported earnings 30 days ago. What's next for the stock?
Vietnam's CMC gets approval for $250-mln hyperscale data centre
Vietnam's tech firm CMC Corp. has got approval from the authorities of Ho Chi Minh City to build a $250-million hyperscale data centre there, it said on Monday.
Commercial Metals Company (CMC) Q3 2025 Earnings Call Transcript
Commercial Metals Company (NYSE:CMC ) Q3 2025 Earnings Conference Call June 23, 2025 11:00 AM ET Company Participants Paul J. Lawrence - Senior VP & CFO Peter R.
